Clinical trial
Combination Chemotherapy With or Without Filgrastim in Treating Patients With…
NCT00008125 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00008125 |
|---|---|
| Title | Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study Of Gemcitabine, Docetaxel And Carboplatin, With And Without Filrastim Support, Combination Chemotherapy In Patients With Advanced Non-Hematological Malignancies |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, carboplatin, docetaxel, gemcitabine hydrochloride |
| Enrollment | 25 |
| Start date | Mar 1, 1998 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | May 4, 2004 |
| Last update posted | Jan 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: